Oppenheimer Reiterates Buy Rating on Lam Research
Oppenheimer maintained its buy rating on Lam Research, setting a target price of $400.
Key Points
- Oppenheimer reiterated its buy rating for Lam Research with a target price of $400 on June 15, 2026.
- Lam Research's stock traded at $385.82 on the NasdaqGS, with a market cap of $458.7 billion and a P/E ratio of 69.47.
- Insider sales included Eric Brandt selling 54,500 shares at $350.80 on June 11, 2026, as part of a planned transaction.
Oppenheimer reiterated its buy rating on Lam Research Corporation (NasdaqGS: LRCX) on June 15, 2026, with a target price of $400. This comes as the stock traded at $385.82, reflecting Oppenheimer's continued confidence in the semiconductor equipment maker.
What Changed in Oppenheimer's Lam Research Position
Oppenheimer's analyst Ed Yang maintained the buy rating for Lam Research, setting a price target of $400. This decision aligns with the firm's positive outlook on the company, which is a leader in semiconductor processing equipment.
Other Institutional Activity in Lam Research
BlackRock, Inc. reduced its stake in Lam Research by 1,407,391 shares, ending with 132,852,320 shares valued at about $28.39 billion. Vanguard Capital Management LLC added 81,155,744 shares, bringing its total to the same amount worth approximately $17.34 billion. State Street Corp trimmed its holdings by 527,784 shares, resulting in 59,158,300 shares valued at $12.65 billion. Geode Capital Management, LLC increased its position by 1,428,558 shares, ending with 35,175,926 shares valued at around $7.50 billion.
Lam Research Stock Snapshot
Shares of Lam Research (NasdaqGS: LRCX) traded near $385.82. The company boasts a market cap of $458.7 billion and a P/E ratio of 69.47, with a forward P/E of 46.04. Its beta is 1.868, indicating higher volatility compared to the market. The stock has seen a 52-week low of $87.75 and a high of $373.82, with a 50-day moving average of $285.93 and a 200-day moving average of $204.48.
Recent Earnings
In its recent earnings report, Lam Research posted revenue of $21.68 billion, marking a growth of 23.8%. The company reported an EPS of $5.28, with a net margin of 30.94% and a return on equity of 66.76%. The next earnings announcement is expected on July 29, 2026.
Dividend
Lam Research pays an annual dividend of $1.04, yielding 0.28%. The payout ratio is relatively low at 19.09%, suggesting the dividend is well-covered by earnings.
Insider Buying and Selling at Lam Research Corporation
Recent insider activity includes Eric Brandt selling 54,500 shares at an average price of $350.80 on June 11, 2026, under a planned transaction. Neil Fernandes, Senior Vice President, sold 7,659 shares at $309.60 on June 1, 2026, also as part of a planned transaction.
Analysts Set New Price Targets
On June 15, 2026, Oppenheimer maintained its buy rating with a $400 target price. Barclays kept a hold rating with a $335 target on June 11, 2026. Cantor Fitzgerald maintained a buy rating with a $425 target on June 10, 2026. Overall, the consensus rating for Lam Research is a buy, with an average target price of $323.38 based on 32 analyst opinions.
About Lam Research
Lam Research Corporation, headquartered in Fremont, California, designs and manufactures semiconductor processing equipment used in the fabrication of integrated circuits. The company operates globally, serving markets in the United States, China, Korea, Taiwan, Japan, Southeast Asia, and Europe. Led by CEO Timothy M. Archer, Lam Research employs approximately 20,600 people.
Bottom Line
Lam Research remains a key player in the semiconductor equipment industry, with Oppenheimer reiterating its buy rating and setting a $400 target. The stock's performance and analyst outlook suggest confidence in its future growth potential. As always, remember that 13F filings and analyst ratings are backward-looking and reflect past positions and opinions.
See Also
This instant news alert was generated by automated narrative technology and financial data from Trueearnings and public regulatory filings. It is for informational purposes only and is not financial advice.